Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324402 · ClinicalTrials.gov registry record
Plasma Brain Natriuretic Peptide Levels in Pregnancy
A clinical trial, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- 50
- Enrollment target
NCT00324402 is a clinical trial that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 50 participants.
The verdict
NCT00324402 has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To evaluate the maternal blood concentrations of brain natriuretic peptide (BNP) during the second and third trimesters of a normal pregnancy. We will attempt to define a normal range for pregnancy and any outliers that may serve as markers for abnormal cardiovascular physiology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00324402
The ClinicalTrials.gov registry entry for NCT00324402 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University Center for Health Sciences, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00324402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00324402 about?
NCT00324402 is a clinical study titled "Plasma Brain Natriuretic Peptide Levels in Pregnancy". To evaluate the maternal blood concentrations of brain natriuretic peptide (BNP) during the second and third trimesters of a normal pregnancy. We will attempt to define a normal range for pregnancy and any outliers that may serve as markers for abnormal cardiovascular physiology.
What is the current status of trial NCT00324402?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2006-08. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00324402?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.